Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $664.98 | 37 | 93.4% |
| Education | $46.91 | 1 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $161.47 | 9 | $0 (2024) |
| ITI, Inc. | $151.86 | 6 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $112.49 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $79.65 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $63.11 | 4 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $49.68 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $35.40 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $16.48 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $15.76 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $13.83 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.69 | 24 | ABBVIE INC. ($161.47) |
| 2023 | $90.87 | 5 | ITI, Inc. ($60.56) |
| 2022 | $170.17 | 8 | ITI, Inc. ($91.30) |
| 2021 | $12.16 | 1 | Eisai Inc. ($12.16) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Neuropsychiatry | ||||||
| 11/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Neuroscience | ||||||
| 07/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Neuroscience | ||||||
| 03/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Neuroscience | ||||||
| 03/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Neuroscience | ||||||
| 01/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 104 | 223 | $50,245 | $12,979 |
| 2022 | 2 | 53 | 196 | $45,975 | $11,479 |
| 2021 | 2 | 59 | 220 | $52,000 | $13,305 |
| 2020 | 4 | 111 | 266 | $63,245 | $13,226 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 160 | $34,020 | $8,135 | 23.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 31 | 33 | $11,725 | $3,974 | 33.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 30 | $4,500 | $869.76 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 181 | $40,725 | $9,754 | 23.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 14 | 15 | $5,250 | $1,725 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 200 | $45,000 | $10,696 | 23.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 18 | 20 | $7,000 | $2,609 | 37.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 181 | $40,545 | $7,933 | 19.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 32 | 34 | $11,900 | $3,405 | 28.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 39 | $7,800 | $1,063 | 13.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $3,000 | $824.16 | 27.5% |
About Mary Ely, NP
Mary Ely, NP is a Nurse Practitioner healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2011. The National Provider Identifier (NPI) number assigned to this provider is 1639477425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Ely, NP has received a total of $711.89 in payments from pharmaceutical and medical device companies, with $438.69 received in 2024. These payments were reported across 38 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($664.98).
As a Medicare-enrolled provider, Ely has provided services to 327 Medicare beneficiaries, totaling 905 services with total Medicare billing of $50,989. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Cleveland, MS
- Active Since 03/03/2011
- Last Updated 10/25/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1639477425
Products in Payments
- CAPLYTA (Drug) $264.35
- VRAYLAR (Drug) $161.47
- INVEGA SUSTENNA (Drug) $79.65
- LATUDA (Drug) $63.11
- Qelbree (Drug) $49.68
- REXULTI (Drug) $35.40
- Austedo XR (Drug) $16.48
- INGREZZA (Drug) $15.76
- QUVIVIQ (Drug) $13.83
- Dayvigo (Drug) $12.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Cleveland
Margaret Bobonich, Cnp, CNP
Nurse Practitioner — Payments: $215,387
Beth Faiman, Cnp, CNP
Nurse Practitioner — Payments: $51,868
Jessica Glennie, Cnp, CNP
Nurse Practitioner — Payments: $34,769
Elizabeth Kirchner, C.n.p, C.N.P
Nurse Practitioner — Payments: $20,217
Loveth Adenuga
Nurse Practitioner — Payments: $12,888
Julie Widmar
Nurse Practitioner — Payments: $11,698